Response of the cellular immune system to cardiopulmonary bypass in vivo

M Misoph1, J Babin-Ebell, S Schwender

  • 1Department of Cardiothoracic Surgery, University Hospital, Würzburg, Germany.

Insights

Cardiopulmonary bypass (CPB) transiently impacts the immune system, causing temporary immunosuppression. This study monitored leukocyte changes during and after coronary artery bypass grafting surgery.

Area of Science:

  • Immunology
  • Cardiovascular Surgery

Background:

  • Cardiopulmonary bypass (CPB) is associated with inflammatory responses.
  • Previous research indicates CPB impairs cellular immunity, activating neutrophils and altering lymphocyte subsets.

Purpose of the Study:

  • To investigate the in vivo effects of CPB on leukocyte activation.
  • To analyze quantitative and qualitative changes in leukocyte populations during and after CPB.

Main Methods:

  • Flow cytometry was used to analyze leukocyte populations.
  • 27 patients undergoing coronary artery bypass grafting were studied.
  • Samples were collected preoperatively, intraoperatively, and postoperatively.

Main Results:

  • Leukocyte counts increased significantly during CPB, leading to postoperative leukocytosis.
  • Lymphocyte counts initially increased then decreased, primarily due to loss of B and cytotoxic T cells.
  • Post-protamine lymphocytopenia was mainly attributed to a decrease in helper T lymphocytes.
  • Distinct leukocyte populations showed activation during and after CPB.

Conclusions:

  • CPB influences the cellular immune system.
  • Immunosuppression due to CPB is detectable but transient.